{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Controlled release oral dosage forms of poorly soluble drugs and uses thereof", "item": "https://www.patentleaderboard.com/patent/9532977"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Controlled release oral dosage forms of poorly soluble drugs and uses thereof

Controlled release oral dosage forms of poorly soluble drugs and uses thereof

US Patent 9532977 · Granted Jan 3, 2017

Estimated economic value: $600,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Probiotic compositions and uses thereof2025
Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl2024
Silicon photonics optical transceiver device2024
Method for preparing nicotinamide mononucleotide cocrystal2024
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindo2024
Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-y2023
Skin penetration enhancing composition and use thereof in preparation of skin de2022
Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione2022
Optical transceiver module and optical cable module2022
Optical transceiver module and optical cable module2022
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindol2021
Optical transceiver module and optical cable module2021